NEWS
뉴스.
- Home
- 뉴스룸
- 뉴스
HEADLINE
새로운 ADC 제품 안내 — Anti-Payload Antibodies 및 50종 이상의 Reference ADC 제공
CONTENT
| Catalog | Product Name | Detects | Host | Application |
| RGP34301 | Anti-MMAE Antibody (SAb2492) | MMAE | Mouse | ELISA |
| RGP34303 | Anti-MMAF Antibody (R4E31) | MMAF | Mouse | ELISA |
| RGP16201 | Anti-DM1 Antibody (SAb2290) | DM1 | Mouse | ELISA |
| RGP34302 | Anti-SN38 Antibody (SAb2493) | SN38 | Rabbit | ELISA |
| RGP33501 | Anti-Deruxtecan/DXd Antibody (SAb2488) | Deruxtecan | Mouse | ELISA |
| Catalog | Product Name | Target |
| DHG52099 | Anetumab ravtansine | Mesothelin |
| DHG52098 | Anetumab-MMAE | Mesothelin |
| DHF92499 | Belantamab mafodotin | BCMA |
| DHD80999 | Brentuximab vedotin | CD30 |
| DHD14299 | Cantuzumab mertansine | CanAg |
| DHD14298 | Cantuzumab ravtansine | CanAg |
| DHD26599 | Carotuximab-MMAE | CD105 |
| DHB86997 | Cetuximab-MMAE | EGFR |
| DHD14297 | Clivatuzumab-MMAE | MUC1 |
| DHE84699 | Codrituzumab-MMAE | GPC3 |
| DHC43399 | Datopotamab deruxtecan | Trop2 |
| DHB86996 | Depatuxizumab mafodotin | EGFR |
| DHC09696 | Disitamab vedotin | HER2 |
| DHD89599 | Enapotamab vedotin | AXL |
| DHJ41099 | Enfortumab vedotin-ejfv | Nectin-4 |
| DHD10497 | Farletuzumab-MMAE | FRA |
| DHG93199 | Glembatumumab vedotin | GPNMB |
| DHE26398 | Iladatuzumab vedotin | CD79b |
| DHD65699 | Indusatumab vedotin | GUCY2C |
| DHC21097 | Labetuzumab govitecan | CEACAM5 |
| DHG52999 | Ladiratuzumab vedotin | LIV-1 |
| DHB86998 | Lapituximab emtansine | EGFR |
| DHB65499 | Lifastuzumab vedotin | NaPi2b |
| DHD10899 | Loncastuximab tesirine | CD19 |
| DHC98599 | Lorvotuzumab mertansine | NCAM |
| DHC98598 | Lorvotuzumab-MMAE | NCAM |
| DHD10499 | Mirvetuximab soravtansine | FRA |
| Catalog | Product Name | Target |
| DHD10498 | Mirvetuximab-MMAE | FRA |
| DHH34799 | Murlentamab-MMAE | AMHR2 |
| DHF90899 | Ozuriftamab vedotin | ROR2 |
| DHD48499 | Patritumab deruxtecan | HER3 |
| DHD38599 | Pinatuzumab vedotin | CD22 |
| DHE26399 | Polatuzumab vedotin-piiq | CD79b |
| DHG64099 | Praluzatamab ravtansine | ALCAM |
| DHG64098 | Praluzatamab-MMAE | ALCAM |
| DHG01399 | Rosopatamab tetraxetan | PSMA |
| DHG01398 | Rosopatamab-MMAE | PSMA |
| DHC43398 | Sacituzumab govitecan | Trop2 |
| DHB86999 | Serclutamab talirine | EGFR |
| DHK06899 | Sirtutamab vedotin | SLITRK6 |
| DHJ31099 | Sofituzumab vedotin | MUC16 |
| DHD72599 | Talacotuzumab-MMAE | IL-3Rα |
| DHC34299 | Telisotuzumab vedotin | cMet |
| DHD89598 | Tilvestamab-MMAE | AXL |
| DHD00699 | Tisotumab vedotin | Tissue Factor |
| DHC09698 | Trastuzumab deruxtecan | HER2 |
| DHC09699 | Trastuzumab emtansine | HER2 |
| DHC09697 | Trastuzumab MMAE | HER2 |
| DHC21099 | Tusamitamab ravtansine | CEACAM5 |
| DHC21098 | Tusamitamab-MMAE | CEACAM5 |
| DHD37599 | Vadastuximab talirine | CD33 |
| DHE01999 | Vorsetuzumab mafodotin | CD70 |
| DHF90799 | Zilovertamab vedotin | ROR1 |
비밀번호 확인